When was SK bioscience founded?

SK bioscience was founded in 2018.

Where is SK bioscience located?

SK bioscience is headquartered in Seongnam-si, South Korea.

How many employees does SK bioscience have?

As of Sep 30, 2026, the latest employee count at SK bioscience is 453.

Where does SK bioscience rank among its competitors?

SK bioscience ranks 2nd amongst 2 active competitors, none of which are funded.

SK bioscience - 2026 Company Profile, Funding & Competitors

Company Details

Developer of vaccines for infectious diseases and recombinant protein therapeutics. It focuses on research and development, production, and global business operations. The company offers a pipeline of products, including vaccines for influenza, shingles, chickenpox, typhoid fever, and COVID-19. It also engages in contract development and manufacturing.

Key Metrics

Founded Year

2018

Location

Seongnam-si, South Korea

Stage

Public

Investors

CEPI & 1 more

Ranked

2^nd among 2 active competitors

Employee Count

453 as on Sep 30, 2026

Investment & Acquisitions

Fina Biosolutions & 4 more

Similar Companies

Pfizer & 476 more

Exit Details

Public

View SK bioscience's full profile

SK bioscience got listed on Mar 18, 2021.

Click here to take a look at SK bioscience's IPO in detail

SK bioscience is a funded company. SK bioscience has 2 institutional investors.

View details of SK bioscience's funding rounds and investors

SK bioscience's employee count trend

SK bioscience has 453 employees as of Sep 26. Here is SK bioscience's employee count trend over the years:

Uncover SK bioscience's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SK bioscience include Pfizer. Here is the list of Top 10 competitors of SK bioscience, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Pfizer 1849, New York City (United States), Public	Provider of pharmaceutical products for multiple disease treatments	-	Berkshire Hathaway, Alcor Fund & 16 others	67/100
2nd	SK bioscience 2018, Seongnam-si (South Korea), Public	Developer of vaccines for infectious diseases and recombinant protein therapeutics	-	CEPI, Hexagon	49/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on SK bioscience's competitors? Click here to see the top ones

SK bioscience has made 4 investments in companies including Fina Biosolutions and Sunflower Therapeutics. SK bioscience has also acquired 1 companies including IDT Biologics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Oct 08, 2024	Investments	Fina Biosolutions	2006	Rockville (United States)
Jun 27, 2024	Acquisition	IDT Biologics	1921	Germany
May 13, 2024	Investments	Sunflower Therapeutics	2018	Hingham (United States)